146 related articles for article (PubMed ID: 35892474)
1. Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency.
Shih STF; Keller E; Wiley V; Wong M; Farrar MA; Chambers GM
Int J Neonatal Screen; 2022 Jul; 8(3):. PubMed ID: 35892474
[TBL] [Abstract][Full Text] [Related]
2. Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency.
Shih STF; Keller E; Wiley V; Farrar MA; Wong M; Chambers GM
Int J Neonatal Screen; 2022 Jul; 8(3):. PubMed ID: 35892475
[TBL] [Abstract][Full Text] [Related]
3. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).
Chan K; Davis J; Pai SY; Bonilla FA; Puck JM; Apkon M
Mol Genet Metab; 2011 Nov; 104(3):383-9. PubMed ID: 21810544
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
5. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
6. Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia.
Sun D; Heimall JR; Greenhawt MJ; Bunin NJ; Shaker MS; Romberg N
JAMA Pediatr; 2022 Feb; 176(2):176-184. PubMed ID: 34779842
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis.
Shih ST; Farrar MA; Wiley V; Chambers G
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1296-1304. PubMed ID: 34321343
[TBL] [Abstract][Full Text] [Related]
8. An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis.
Sharma R; Gu Y; Sinha K; Ching TYC; Marnane V; Gold L; Wake M; Wang J; Parkinson B
Ear Hear; 2022; 43(3):972-983. PubMed ID: 34772837
[TBL] [Abstract][Full Text] [Related]
9. A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK.
Bessey A; Chilcott J; Leaviss J; de la Cruz C; Wong R
Int J Neonatal Screen; 2019 Sep; 5(3):28. PubMed ID: 33072987
[TBL] [Abstract][Full Text] [Related]
10. Combined population genomic screening for three high-risk conditions in Australia: a modelling study.
Lacaze P; Marquina C; Tiller J; Brotchie A; Kang YJ; Merritt MA; Green RC; Watts GF; Nowak KJ; Manchanda R; Canfell K; James P; Winship I; McNeil JJ; Ademi Z
EClinicalMedicine; 2023 Dec; 66():102297. PubMed ID: 38192593
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of newborn screening for severe combined immunodeficiency.
Van der Ploeg CPB; Blom M; Bredius RGM; van der Burg M; Schielen PCJI; Verkerk PH; Van den Akker-van Marle ME
Eur J Pediatr; 2019 May; 178(5):721-729. PubMed ID: 30805731
[TBL] [Abstract][Full Text] [Related]
12. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of cervical length screening and progesterone treatment to prevent spontaneous preterm delivery in Sweden.
Wikström T; Kuusela P; Jacobsson B; Hagberg H; Lindgren P; Svensson M; Wennerholm UB; Valentin L
Ultrasound Obstet Gynecol; 2022 Jun; 59(6):778-792. PubMed ID: 35195310
[TBL] [Abstract][Full Text] [Related]
14. Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program.
Sruamsiri R; Chaiyakunapruk N; Pakakasama S; Sirireung S; Sripaiboonkij N; Bunworasate U; Hongeng S
BMC Health Serv Res; 2013 Feb; 13():45. PubMed ID: 23379888
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
Ding Y; Thompson JD; Kobrynski L; Ojodu J; Zarbalian G; Grosse SD
J Pediatr; 2016 May; 172():127-35. PubMed ID: 26876279
[TBL] [Abstract][Full Text] [Related]
16. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
Wali AR; Park CC; Brown JM; Mandeville R
Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
[TBL] [Abstract][Full Text] [Related]
17. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
18. Five-layer border dressings as part of a quality improvement bundle to prevent pressure injuries in US skilled nursing facilities and Australian nursing homes: A cost-effectiveness analysis.
Padula WV; Chen YH; Santamaria N
Int Wound J; 2019 Dec; 16(6):1263-1272. PubMed ID: 31475434
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
